Search Results - "Tse, A.N."

Phase I Dose-Finding Study of Weekly Docetaxel Followed by Flavopiridol for Patients with Advanced Solid Tumors by FORNIER, M. N, RATHKOPF, D, SHAH, M, PATIL, S, O'REILLY, E, TSE, A. N, HUDIS, C, LEFKOWITZ, R, KELSEN, D. P, SCHWARTZ, G. K

“…Purpose: Flavopiridol is a cyclin-dependent kinase inhibitor that enhances docetaxel-induced apoptosis in a sequence-specific manner. In vivo , docetaxel must…”
Get full text

981P Preliminary safety and efficacy results from phase Ib study of the anti-CTLA-4 monoclonal antibody (mAb) CS1002 in combination with anti-PD-1 mAb CS1003 in patients with advanced solid tumors by Bishnoi, S., Cosman, R., Moore, M., Eek, R., Mant, A., Zielinski, R., Chan, L.S., Ma, Y., Zhang, Q., Yau, T., Aghmesheh, M., Tse, A.N.

Get full text